{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:44Z","timestamp":1790716784179,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI081677"],"award-info":[{"award-number":["AI081677"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI100148"],"award-info":[{"award-number":["AI100148"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1033115"],"award-info":[{"award-number":["OPP1033115"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1124068"],"award-info":[{"award-number":["OPP1124068"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1032144"],"award-info":[{"award-number":["OPP1032144"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR Mathilde Krim Fellowship in Basic Biomedical Research","doi-asserted-by":"publisher","award":["108977-57-RKVA"],"award-info":[{"award-number":["108977-57-RKVA"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cell.2016.04.050","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T11:29:03Z","timestamp":1466162943000},"page":"1609-1620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency"],"prefix":"10.1016","volume":"165","author":[{"given":"Stylianos","family":"Bournazos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gazumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey V.","family":"Ravetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2016.04.050_bib1","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1128\/JVI.02097-15","article-title":"Bispecific antibodies targeting different epitopes on the HIV-1 envelope exhibit broad and potent neutralization","volume":"89","author":"Asokan","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2016.04.050_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"Blattner","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2016.04.050_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12343","article-title":"Fc\u03b3 receptor pathways during active and passive immunization","volume":"268","author":"Bournazos","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cell.2016.04.050_bib5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in\u00a0vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2016.04.050_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2016.04.050_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in HIV-1 infection","volume":"16","author":"Burton","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2016.04.050_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/mabs.1.6.10015","article-title":"Bispecific antibodies for cancer therapy: the light at the end of the tunnel?","volume":"1","author":"Chames","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.cell.2016.04.050_bib10","doi-asserted-by":"crossref","first-page":"e1004767","DOI":"10.1371\/journal.ppat.1004767","article-title":"Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer","volume":"11","author":"Derking","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2016.04.050_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20130221","article-title":"Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies","volume":"210","author":"Diskin","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2016.04.050_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2015.01.016","article-title":"Intra-spike crosslinking overcomes antibody evasion by HIV-1","volume":"160","author":"Galimidi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2016.04.050_bib13","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1128\/JVI.78.11.5983-5995.2004","article-title":"Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies","volume":"78","author":"Haigwood","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2016.04.050_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2014.07.043","article-title":"Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice","volume":"158","author":"Halper-Stromberg","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2016.04.050_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib16","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1315295110","article-title":"HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice","volume":"110","author":"Horwitz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib19","doi-asserted-by":"crossref","first-page":"e1003342","DOI":"10.1371\/journal.ppat.1003342","article-title":"Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans","volume":"9","author":"Julien","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2016.04.050_bib20","doi-asserted-by":"crossref","first-page":"e1000908","DOI":"10.1371\/journal.ppat.1000908","article-title":"Few and far between: how HIV may be evading antibody avidity","volume":"6","author":"Klein","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2016.04.050_bib21","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1073\/pnas.0811427106","article-title":"Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10","volume":"106","author":"Klein","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1084\/jem.20120423","article-title":"Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein","volume":"209","author":"Klein","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2016.04.050_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"Klein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cell.2016.04.050_bib25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"Kong","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2016.04.050_bib26","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes","volume":"89","author":"Kong","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2016.04.050_bib27","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1038\/ncomms9167","article-title":"Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike","volume":"6","author":"Lee","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2016.04.050_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib29","doi-asserted-by":"crossref","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2016.04.050_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nbt0798-677","article-title":"An efficient route to human bispecific IgG","volume":"16","author":"Merchant","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2016.04.050_bib31","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","volume":"12","author":"Montefiori","year":"2005","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cell.2016.04.050_bib32","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm.2233","article-title":"Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques","volume":"16","author":"Ng","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2016.04.050_bib34","doi-asserted-by":"crossref","first-page":"13540","DOI":"10.1073\/pnas.1304985110","article-title":"Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1","volume":"110","author":"Pace","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib35","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1038\/ncomms9447","article-title":"Activation and lysis of human CD4 cells latently infected with HIV-1","volume":"6","author":"Pegu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2016.04.050_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cell.2016.04.050_bib37","doi-asserted-by":"crossref","first-page":"15859","DOI":"10.1073\/pnas.1213409109","article-title":"A mouse model for HIV-1 entry","volume":"109","author":"Pietzsch","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"\u2018Knobs-into-holes\u2019 engineering of antibody CH3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.cell.2016.04.050_bib39","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.4049\/jimmunol.159.7.3372","article-title":"Flexibility of human IgG subclasses","volume":"159","author":"Roux","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2016.04.050_bib40","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.4049\/jimmunol.161.8.4083","article-title":"Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry","volume":"161","author":"Roux","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2016.04.050_bib41","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.1019002108","article-title":"Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies","volume":"108","author":"Schaefer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2016.04.050_bib42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.cell.2015.08.035","article-title":"Broadly neutralizing antibody 8ANC195 recognizes closed and open states of HIV-1 Env","volume":"162","author":"Scharf","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2016.04.050_bib43","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cell.2016.04.050_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"Shingai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib45","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"Sok","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2 Pt A","key":"10.1016\/j.cell.2016.04.050_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2015.01.003","article-title":"Alternative molecular formats and therapeutic applications for bispecific antibodies","volume":"67","author":"Spiess","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cell.2016.04.050_bib47","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1172\/JCI82314","article-title":"Dual-affinity re-targeting proteins direct T\u00a0cell-mediated cytolysis of latently HIV-infected cells","volume":"125","author":"Sung","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2016.04.050_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cell.2016.04.050_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2016.04.050_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tibs.2014.12.006","article-title":"Insights into the trimeric HIV-1 envelope glycoprotein structure","volume":"40","author":"Ward","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cell.2016.04.050_bib51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors","volume":"161","author":"Zhou","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2016.04.050_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature04817","article-title":"Distribution and three-dimensional structure of AIDS virus envelope spikes","volume":"441","author":"Zhu","year":"2006","journal-title":"Nature"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867416304950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867416304950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:03:00Z","timestamp":1717214580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867416304950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0092867416304950"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2016.04.050","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2016.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2016.05.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}